ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Continuation Of Cancer Genome Atlas Network.

December 19, 2008

Carlson Named NCCN Chief Executive

September 28, 2012

Report on Carcinogens Lists Estrogen, UV Light, Wood Dust;

January 10, 2003

Fox Retirement Marks End of Era for NCI Construction Program

October 6, 1989

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

Facilities Survey To Include All Institutions With $200,000 Or More in NCI Support

October 5, 1984